---
title: GNS Healthcare Blog | orphan drugs
description: orphan drugs |
---

- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)

- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)

[![GNS](https://info.aitiabio.com/hubfs/GNS_Healthcare_October2018%20Theme/Images/gns_logo.png)](https://www.gnshealthcare.com/)

 

- Solutions 
    - [REFS Platform](https://www.gnshealthcare.com/refs-platform/)
    - [Subpopulations](https://www.gnshealthcare.com/subpopulations/)
    - [Value-based Drug Models](https://www.gnshealthcare.com/value-based-drug-models/)
    - [Intervention Optimization](https://www.gnshealthcare.com/intervention-optimization/)
    - [Customized Modeling](https://www.gnshealthcare.com/customized-modeling/)
- Who We Serve 
    - [Biopharma](https://www.gnshealthcare.com/biopharma/)
    - [Health Plans](https://www.gnshealthcare.com/health-plans/)
    - [Foundations](https://www.gnshealthcare.com/foundations/)
- Results 
    - [The Power of Causal Machine Learning](https://www.gnshealthcare.com/the-power-of-causal-machine-learning/)
    - [Journal Articles](https://www.gnshealthcare.com/journal-articles/)
    - [Posters](https://www.gnshealthcare.com/posters/)
- [News & Events](https://www.gnshealthcare.com/news/) 
    - [Blog](https://blog.gnshealthcare.com/)
    - [In the News](https://www.gnshealthcare.com/news/#news)
    - [Events](https://www.gnshealthcare.com/news/#events)
    - [Press Releases](https://www.gnshealthcare.com/news/#press-releases)
    - [GNS Precision Medicine Forum](https://www.gnshealthcare.com/gns-precision-medicine-forum/)
- About Us 
    - [Leadership](https://www.gnshealthcare.com/leadership/)
    - [Board of Directors](https://www.gnshealthcare.com/board-of-directors/)
    - [Strategic Advisory Board](https://www.gnshealthcare.com/strategic-advisory-board/)
    - [Our Culture](https://www.gnshealthcare.com/culture/)
    - [Careers](https://www.gnshealthcare.com/careers/)
    - [Contact](https://www.gnshealthcare.com/contact/)
- [Request Info](https://info.gnshealthcare.com/request-info-website)
- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)

## GNS Healthcare Blog

# GNS Healthcare Blog

## GNS Healthcare Primary Blog

 By <https://info.aitiabio.com/author/> December 31, 1969

Jun 20

[![iStock-912610730](https://info.aitiabio.com/hubfs/iStock-912610730.jpg)](https://info.aitiabio.com/enough-is-enough-paving-the-way-for-orpha-drugs)

## [Paving the Way for Orphan Drugs with AI and Data](https://info.aitiabio.com/enough-is-enough-paving-the-way-for-orpha-drugs)

By [GNS Healthcare](https://info.aitiabio.com/author/gns-healthcare)  | [AI](https://info.aitiabio.com/topic/ai), [Future](https://info.aitiabio.com/topic/future), [Healthcare](https://info.aitiabio.com/topic/healthcare), [Innovation](https://info.aitiabio.com/topic/innovation), [orphan drugs](https://info.aitiabio.com/topic/orphan-drugs)

Chances are, you know of someone who suffers from multiple myeloma, non-Hodgins lymphoma or multiple-sclerosis. Despite the familiarity of those conditions, all three are considered rare-diseases by the U.S. Food and Drug Administration (FDA) because they affect less than 200,000 people in the U.S.[\[1\]](https://info.aitiabio.com/topic/orphan-drugs#_ftn1)

According to estimates by the National Institute of Health, there may be as many as 7,000 rare diseases affecting approximately 25-35 million Americans.\[2\]   So what do rare diseases have to do with AI?   

[Read More](https://info.aitiabio.com/enough-is-enough-paving-the-way-for-orpha-drugs)

### Subscribe to the GNS Newsletter

Search:

Search

### Follow Us:

<https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg?sub_confirmation=1><https://twitter.com/gnshealthcare><https://www.linkedin.com/company/1608800>

### Recent Posts:

### Categories:

- [AI (29)](https://info.aitiabio.com/topic/ai)
- [Precision Medicine (21)](https://info.aitiabio.com/topic/precision-medicine)
- [Artificial Intelligence (20)](https://info.aitiabio.com/topic/artificial-intelligence)
- [Machine Learning (20)](https://info.aitiabio.com/topic/machine-learning)
- [Future (13)](https://info.aitiabio.com/topic/future)
- [Big Data (12)](https://info.aitiabio.com/topic/big-data)
- [Healthcare (11)](https://info.aitiabio.com/topic/healthcare)

### Twitter

[Tweets by @gnshealthcare](https://twitter.com/gnshealthcare)

**About GNS Healthcare**  
 By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals. We understand that in order to make precision medicine a reality, we need to discover and deliver insights that will cure disease and heal the healthcare system.

[Privacy Policy](https://www.gnshealthcare.com/privacy-policy)

![HITRUST](https://info.aitiabio.com/hubfs/GNS_Healthcare_October2018%20Theme/Images/HiTrust-Certified.jpg)

**Contact Us**  
 196 Broadway  
 Cambridge, MA 02139  
 Email: [info@gnshealthcare.com](mailto:info@gnshealthcare.com)  
 Phone: 617.374.2300

- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)

© GNS Healthcare 561 Windsor St. A200, Somerville, MA 02143 | 617-374-2300